ANNE MARIE FETTER: Open Payments
NPI 1689078875 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 27 payments from 9 companies in 2025. Trend: 2023 $289 · 2024 $409 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $208 |
| Madrigal Pharmaceuticals | 2 | $148 |
| ABBVIE INC. | 5 | $130 |
| Aimmune Therapeutics, Inc. | 3 | $77 |
| Lilly USA, LLC | 3 | $56 |
| VIVUS LLC | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Corcept Therapeutics | 1 | $23 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: Wegovy, REZDIFFRA, LINZESS, CREON, QSYMIA, VOQUEZNA, ZENPEP, ZEPBOUND.
Industry payments across IL — which companies pay providers there.
